Atreca Inc (BCEL)
$0.00 $0.00 (0.00%) 4:37 PM 12/14/24
PINK | $USD | BiotechnologyStock Data
-
Market Cap
$2.87M -
Day's Range
- - - -
Volume
128,187 -
52 Week Low / High
$0.05 - $1.26 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
BCEL's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 2
- Strong Buy
- 0
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong Sell
- $3.25
- Target Price
Company News
-
Atreca Announces Asset Purchase Agreement for Sale of Antibody-Related Assets and Materials to Immunome — Dec 26th, 2023
Atreca, Inc. CAMPBELL, Calif., Dec. 26, 2023 (GLOBE NEWSWIRE) -- Atreca, Inc. (“Atreca”) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune response, today ann...
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$